- Home
- YMAB vs NAT Comparison
YMAB vs NAT Comparison
Compare YMAB & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- NAT
- Stock Information
- Founded
- YMAB 2015
- NAT 1995
- Country
- YMAB United States
- NAT Bermuda
- Employees
- YMAB N/A
- NAT N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- YMAB Health Care
- NAT Consumer Discretionary
- Exchange
- YMAB Nasdaq
- NAT Nasdaq
- Market Cap
- YMAB 482.4M
- NAT 517.8M
- IPO Year
- YMAB 2018
- NAT 1997
- Fundamental
- Price
- YMAB $6.19
- NAT $2.66
- Analyst Decision
- YMAB Strong Buy
- NAT Hold
- Analyst Count
- YMAB 10
- NAT 2
- Target Price
- YMAB $21.10
- NAT $3.75
- AVG Volume (30 Days)
- YMAB 417.3K
- NAT 3.0M
- Earning Date
- YMAB 02-27-2025
- NAT 02-27-2025
- Dividend Yield
- YMAB N/A
- NAT 15.01%
- EPS Growth
- YMAB N/A
- NAT N/A
- EPS
- YMAB N/A
- NAT 0.30
- Revenue
- YMAB $84,553,000.00
- NAT $367,467,000.00
- Revenue This Year
- YMAB $6.09
- NAT N/A
- Revenue Next Year
- YMAB $19.62
- NAT $17.77
- P/E Ratio
- YMAB N/A
- NAT $9.19
- Revenue Growth
- YMAB N/A
- NAT N/A
- 52 Week Low
- YMAB $6.01
- NAT $2.41
- 52 Week High
- YMAB $20.90
- NAT $4.55
- Technical
- Relative Strength Index (RSI)
- YMAB 19.68
- NAT 45.79
- Support Level
- YMAB $6.05
- NAT $2.47
- Resistance Level
- YMAB $6.81
- NAT $2.61
- Average True Range (ATR)
- YMAB 0.49
- NAT 0.11
- MACD
- YMAB -0.02
- NAT 0.03
- Stochastic Oscillator
- YMAB 6.90
- NAT 40.98
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.